To the Editor: The research article by Keogh and colleagues1 on uptake of genetic testing and insurance implications highlights the need to ensure that Australian insurance industry policy in relation to genetic testing does not increase the risk of adverse health outcomes.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- National Health and Medical Research Council, Canberra, ACT.
Correspondence: nhmrc@nhmrc.gov.au
- 1. Keogh LA, van Vliet CM, Studdert DM, et al. Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? Med J Aust 2009; 191: 255-258. <MJA full text>
- 2. Barlow-Stewart K, Taylor SD, Treloar SA, et al. Verification of consumers’ experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing. Genet Med 2009; 11: 193-201.
Online responses are no longer available. Please refer to our instructions for authors page for more information.